Skip to content
Disclosery

EXANE DERIVATIVES: MTD position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on MTD, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 413 MTD shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 413 shares
    Change vs previous 13F +59 shares

    0.27% of the 13F portfolio, value $474,345.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 354 shares
    Change vs previous 13F -94 shares

    0.14% of the 13F portfolio, value $486,079.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 448 shares
    Change vs previous 13F +116 shares

    0.18% of the 13F portfolio, value $760,323.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 332 shares
    Change vs previous 13F -22 shares

    0.11% of the 13F portfolio, value $457,267.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 354 shares
    Change vs previous 13F -36 shares

    0.12% of the 13F portfolio, value $510,524.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 390 shares
    Change vs previous 13F -12 shares

    0.14% of the 13F portfolio, value $450,699.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 402 shares
    Change vs previous 13F -74 shares

    0.14% of the 13F portfolio, value $458,130.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 476 shares
    Change vs previous 13F not available

    0.15% of the 13F portfolio, value $459,672.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).